Haypp Group AB reported robust growth in its Q4 2024 earnings, driven by a 16% increase in nicotine pouch volume and significant advancements in both core and growth markets. The company's stock ...

The U.S. Food and Drug Administration (FDA) has authorized the marketing of Zyn nicotine pouches as a reduced-risk ...

While investors in the tobacco space have tended to be more focused on dividends over the years, Philip Morris International ...